DrugRisk Adds Update as Court Order Sets Pradaxa Trial Date and Bellwether Cases

Share Article

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

pradaxa lawsuit
Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options.

The prescription drug safety advocates at DrugRisk.com are alerting patients taking the blood thinner Pradaxa of updated legal news on the site. A federal judge overseeing hundreds of lawsuits alleging Pradaxa internal bleeding has issued an order setting rules for the upcoming start of trials.

DrugRisk was created to improve the safety of those taking prescription drugs by sharing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Experts have disagreed over whether Pradaxa, launched in 2010 to prevent strokes in patients with atrial fibrillation, causes higher risks of internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin*.

The Institute for Safe Medication Practices, however, warned that patients suffering Pradaxa bleeding are almost 5 times as likely to die than those with bleeding from warfarin. They also named anticoagulants like Pradaxa among the most dangerous drugs**.

Already, more than 260 patients have filed a Pradaxa lawsuit alleging internal bleeding from the drug, which have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, Judge David Herndon, who is presiding over the cases, has issued an order scheduling the first trial to start on August 11, 2014. He also ordered that lawyers prepare 16 cases for early discovery and trial, which will serve as “bellwether” cases to gauge future litigation***.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2323437.0.pdf#search="pradaxa"

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website